Literature DB >> 2894390

Androgen producing adrenal adenoma. Report on a case associated with hyperparathyroidism.

P J Guillausseau1, C Boitard, Y Le Charpentier, L Cedard, K Nahoul, C Blacker, E Kaloustian, F Courtalhac-Kaloustian, C Dubost, J Lubetzki.   

Abstract

In a 41-year-old hirsute woman, severe hypercalcemia led to the discovery of hyperparathyroidism related to the involvement (hyperplasia/or adenoma) of the 4 parathyroid glands. Plasma and urinary DHA, plasma DHA-sulfate and delta 5 steroid precursors were elevated. Steroid hormone hypersecretion was stimulated by hCG and ACTH, and exhibited a paradoxical rise during dexamethasone administration. Computerized tomography scanning as well as arteriography disclosed bilateral adrenal hyperplasia and left adrenal adenoma. Bilateral adrenal vein catheterization indicated a left/right gradient for delta 5 steroids and delta 5 steroid sulfates. At surgery a left brown adrenal encapsulated adenoma was removed with a hyperplastic adrenal gland. Results of in vitro studies (adrenal steroid content and incubation) together with postadrenalectomy hormonal results suggest that the left brown adrenal adenoma was the main source of excessive androgen production. The infrequent association of an androgen-producing adrenal adenoma with hyperparathyroidism raises the hypothesis of multiple endocrine neoplasia syndrome. However, evidence for this diagnosis is lacking in the absence of other glandular involvement and of family history.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2894390     DOI: 10.1007/BF03347005

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  [Rapid chromatographic analysis of urinary 17-ketosteroids].

Authors:  M DROSDOWSKY; R SCHOLLER; M F JAYLE
Journal:  Bull Soc Chim Biol (Paris)       Date:  1961-11-28

2.  Functioning and nonfunctioning adrenal cortical tumors.

Authors:  P HEINBECKER; L W O'NEAL; L V ACKERMAN
Journal:  Surg Gynecol Obstet       Date:  1957-07

3.  [Plasma androgens in boys from birth to adolescence].

Authors:  M Roger; K Nahoul; J E Toublanc; M Castanier; P Canlorbe; J C Job
Journal:  Ann Pediatr (Paris)       Date:  1979-04

4.  Ultrastructural and steroidogenic characteristics of an androgen-producing adrenocortical tumour.

Authors:  I Huhtaniemi; A I Kahri; R Pelkonen; M Salmenperä; A Sivula; R Vihko
Journal:  Clin Endocrinol (Oxf)       Date:  1978-04       Impact factor: 3.478

5.  Male external genitalia of a girl caused by a virilizing adrenal tumour in the mother. Case report and steroid studies.

Authors:  G Mürset; M Zachmann; A Prader; J Fischer; A Labhart
Journal:  Acta Endocrinol (Copenh)       Date:  1970-12

6.  Virilization of a post-menopausal woman by a testosterone-secreting Leydig cell type adrenal adenoma.

Authors:  B N Trost; M P Koenig; A Zimmermann; M Zachmann; J Müller
Journal:  Acta Endocrinol (Copenh)       Date:  1981-10

7.  Occurrence of other endocrine tumours in primary hyperparathyroidism.

Authors:  J H Boey; T J Cooke; G M Gilbert; E C Sweeney; S Taylor
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

8.  Radioimmunoassay of plasma and urine 6 beta-hydroxycortisol: levels in healthy adults and in hypercortisolemic states.

Authors:  K Nahoul; J Adeline; F Paysant; R Scholler
Journal:  J Steroid Biochem       Date:  1982-09       Impact factor: 4.292

9.  Testicular secretion of conjugated and unconjugated steroids in normal adults and in patients with varicocele. Baseline levels and time-course response to hCG administration.

Authors:  R Scholler; K Nahoul; M Castanier; J Rotman; J Salat-Baroux
Journal:  J Steroid Biochem       Date:  1984-01       Impact factor: 4.292

10.  Simultaneous radioimmunoassay of plasma progesterone and 17-hydroxyprogesterone normal values in children, in men and in women throughout the menstrual cycle and in early pregnancy.

Authors:  N T Tea; M Castanier; M Roger; R Scholler
Journal:  J Steroid Biochem       Date:  1975 Nov-Dec       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.